Stay updated on Nivolumab vs. Everolimus in RCC: Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.

Latest updates to the Nivolumab vs. Everolimus in RCC: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPublication note updated to indicate PubMed-derived publications are automatically filled and may not be about the study, and the revision tag changed to v3.3.2 (from v3.2.0).SummaryDifference0.0%

- Check20 days agoChange DetectedRemoved the generic government funding/operating status notice from the page. This deletion does not affect the trial content or user actions.SummaryDifference0.1%

- Check34 days agoChange DetectedNo significant changes were detected in the study record between the screenshots; the core content (title, conditions, interventions, eligibility criteria, outcomes, and locations) appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedImportant updates include a notice about government funding impacts and operating status, plus a new version (v3.2.0); the old version tag (v3.1.0) was removed. If no other major content changes are present, this represents an operational update rather than a broad content overhaul.SummaryDifference2%

- Check70 days agoChange DetectedCore terminology updated from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' and the document/page version bumped to v3.1.0.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page revision is updated from v3.0.1 to v3.0.2, signaling a new release; the 'Back to Top' link was removed, a minor UX change.SummaryDifference0.1%

Stay in the know with updates to Nivolumab vs. Everolimus in RCC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.